Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

physicians total care, inc. - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets, usp are indicated for the reduction of symptoms of intermittent claudication, as indicated by an increased walking distance. cilostazol and several of its metabolites are inhibitors of phosphodiesterase iii. several drugs with this pharmacologic effect have caused decreased survival compared to placebo in patients with class iii-iv congestive heart failure. cilostazol tablets, usp are contraindicated in patients with congestive heart failure of any severity. cilostazol tablets, usp are contraindicated in patients with haemostatic disorders or active pathologic bleeding, such as bleeding peptic ulcer and intracranial bleeding. cilostazol tablets, usp inhibit platelet aggregation in a reversible manner. cilostazol tablets, usp are contraindicated in patients with known or suspected hypersensitivity to any of its components.

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

carilion materials management - cilostazol (unii: n7z035406b) (cilostazol - unii:n7z035406b) - cilostazol 100 mg - cilostazol tablets are indicated for the reduction of symptoms of intermittent claudication, as demonstrated by an increased walking distance. cilostazol is contraindicated in patients with: hypersensitivity to cilostazol or any components of cilostazol (e.g., anaphylaxis, angioedema). teratogenic effects: pregnancy category c . cilostazol has been shown to be teratogenic in rats at doses that are greater than 5-times the human mrhd on a body surface area basis. there are no adequate and well-controlled studies in pregnant women. in a rat developmental toxicity study, oral administration of 1000 mg cilostazol/kg/day was associated with decreased fetal weights, and increased incidences of cardiovascular, renal, and skeletal anomalies (ventricular septal, aortic arch and subclavian artery abnormalities, renal pelvic dilation, 14th rib, and retarded ossification). at this dose, systemic exposure to unbound cilostazol in nonpregnant rats was about 5 times the exposure in humans given the mrhd. increased inciden

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

mayne pharma - estazolam (unii: 36s3eqv54c) (estazolam - unii:36s3eqv54c) - estazolam is indicated for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. both outpatient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance (see clinical pharmacology ). because insomnia is often transient and intermittent, the prolonged administration of estazolam is generally neither necessary nor recommended. since insomnia may be a symptom of several other disorders, the possibility that the complaint may be related to a condition for which there is a more specific treatment should be considered. there is evidence to support the ability of estazolam to enhance the duration and quality of sleep for intervals up to 12 weeks (see clinical pharmacology ). estazolam is contraindicated with ketoconazole and itraconazole, since these medications significantly impair oxidative metabolism mediated by cyp3a (see warnings and precau

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

novitium pharma llc - estazolam (unii: 36s3eqv54c) (estazolam - unii:36s3eqv54c) - estazolam is indicated for the short-term management of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. both outpatient studies and a sleep laboratory study have shown that estazolam administered at bedtime improved sleep induction and sleep maintenance (see clinical pharmacology ). because insomnia is often transient and intermittent, the prolonged administration of estazolam is generally neither necessary nor recommended. since insomnia may be a symptom of several other disorders, the possibility that the complaint may be related to a condition for which there is a more specific treatment should be considered. there is evidence to support the ability of estazolam to enhance the duration and quality of sleep for intervals up to 12 weeks (see clinical pharmacology ). estazolam is contraindicated with ketoconazole and itraconazole, since these medications significantly impair oxidative metabolism mediated by cyp3a (see warnings and precau

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - acetazolamide (unii: o3fx965v0i) (acetazolamide - unii:o3fx965v0i) - acetazolamide 250 mg - for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. acetazolamide tablets are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness in climbers attempting rapid ascent and in those who are very susceptible to acute mountain sickness despite gradual ascent. acetazolamide therapy is contraindicated in situations in which sodium and/or potassium blood serum levels are depressed, in cases of marked kidney and liver disease or dysfunction, in suprarenal gland failure, and in hyperchloremic acidosis. it is contraindicated in patients with cirrhosis because of the risk of development of hepatic encephalopathy. long-term administration of acetazolamide is contraindicated in patients with chroni

Malta - Englisch - Medicines Authority

uriach consumer healthcare sl av. cami reial, 51-57, 08184 palau- solita i plegamans, barcelona, spain - oxymetazoline hydrochloride - nasal spray, solution - oxymetazoline hydrochloride 0.5 mg/ml - nasal preparations

Malta - Englisch - Medicines Authority

hosptess kft limited h-1028 budapest, urberes ut 46, hungary - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents

Malta - Englisch - Medicines Authority

pharmacare srl via marghera, 29 20149, milan, italy - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents

Malta - Englisch - Medicines Authority

labormed pharma sa 44b theodor pallady blvd., 3rd district, bucharest, romania - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents

Malta - Englisch - Medicines Authority

generics uk limited - cilostazol - tablet - cilostazol 100 mg - antithrombotic agents